ArticleJournal of clinical medicine2026

HER-2 Altered Early-Stage Non-Small Cell Lung Cancer Had Better Survival than Triple-Negative Disease.

Tawee Tanvetyanon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.